# Indocyanine Green Versus Blue Dye for Detection of Sentinel Lymph Node In Endometrial Cancer

> **NCT02564276** · PHASE3 · COMPLETED · sponsor: **Centre hospitalier de l'Université de Montréal (CHUM)** · enrollment: 132 (actual)

## Conditions studied

- Endometrial Neoplasms

## Interventions

- **PROCEDURE:** Sentinel lymph node biopsy

## Key facts

- **NCT ID:** NCT02564276
- **Lead sponsor:** Centre hospitalier de l'Université de Montréal (CHUM)
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-02
- **Primary completion:** 2017-04
- **Final completion:** 2017-07
- **Target enrollment:** 132 (ACTUAL)
- **Last updated:** 2018-01-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02564276

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02564276, "Indocyanine Green Versus Blue Dye for Detection of Sentinel Lymph Node In Endometrial Cancer". Retrieved via AI Analytics 2026-06-13 from https://api.ai-analytics.org/clinical/NCT02564276. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*